Oncotelic Therapeutics Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

OTLC Stock

USD 0.03 -0.01 -25.40%

This cycle indicators tool runs Hilbert Transform Dominant Cycle Period indicator and companion studies for Oncotelic Therapeutics. Signals here center on cycle timing and phase shifts in Oncotelic Therapeutics price series alongside volatility and performance references.

Symbol

Indicator

The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Oncotelic Therapeutics price series in order to analyze variations of the instantaneous cycles.

Oncotelic Therapeutics Technical Analysis Modules

Most technical analysis of Oncotelic Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Oncotelic from various momentum indicators to cycle indicators. When you analyze Oncotelic charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

OTC Stock Overview, Methodology & Data Sources

Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing drugs for the treatment of orphan oncology indications. It also develops OXi4503 for the treatment of acute myeloid leukemia and myelodysplastic syndromes and CA4P for the treatment of advanced metastatic melanoma. Oncotelic Therapeutics operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 16 people. This overview emphasizes how Oncotelic Therapeutics compares to peers on valuation quality and operating consistency. Current metrics include P/E of 2.16, P/B of 0.89. Oncotelic Therapeutics has a market cap of 23.9 M, P/E of 2.16, ROE of 49.67%.

Methodology

Unless otherwise specified, financial data for Oncotelic Therapeutics is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Oncotelic (USA Stocks:OTLC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: The dataset for Oncotelic Therapeutics incorporates public filings and market reference sources and official institutional disclosures, including U.S. Securities and Exchange Commission (SEC) via EDGAR. Some inputs may not update instantaneously. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Oncotelic Therapeutics may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Oncotelic Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Oncotelic Therapeutics' short interest history, or implied volatility extrapolated from Oncotelic Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.

	Video Games Invested few shares	Go
	Hedge Favorites Invested over 20 shares	Go
	Macroaxis Index Invested over 60 shares	Go
	Cash Cows Invested few shares	Go
	Blockchain Invested few shares	Go
	Artificial Intelligence Invested few shares	Go
	Macroaxis Picks Invested few shares	Go
	Impulse Invested over 200 shares	Go
	ESG Investing Invested few shares	Go
	Momentum Invested few shares	Go
	Driverless Cars Invested few shares	Go

More Resources for Oncotelic OTC Stock Analysis

Other Information on Investing in Oncotelic OTC Stock

Financial ratios for Oncotelic Therapeutics help frame valuation context across profits, cash flow, and enterprise value. They help compare Oncotelic across measures in a consistent way.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC